PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Levothyroxine linked to short-term creatinine improvement in hypothyroid inpatients

levothyroxinethyroid hormone replacementhypothyroidismrenal dysfunctionchronic kidney diseaseeGFRserum creatinineretrospective cohortendocrinologythyroid-renal axis Endocrinology / Diabetes / Obesity

Background Information

Thyroid hormone therapy reverses renal dysfunction in hypothyroidism.

Hypothyroidism is linked to renal dysfunction, which may be reversible with thyroid hormone replacement, affecting patient outcomes. Levothyroxine therapy significantly reduced serum creatinine from 114.88 ± 25.61 to 79.92 ± 5.64 μmol/L and improved estimated glomerular filtration rate from 51.42 ± 16.32 to 75.04 ± 14.52 mL/min/1.73 m². The study indicates renal dysfunction in hypothyroidism might be reversible but is limited by its small sample size, retrospective nature, and potential confounding. Thyroid hormone replacement may improve renal function in hypothyroid patients.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Zhao T, Zhang N, Tian Y, Yang Z

Citation: Zhao T, Zhang N, Tian Y, et al. Thyroid hormone replacement is associated with improvement in renal dysfunction in patients with hypothyroidism: a retrospective observational study. Frontiers in endocrinology. 2026;17:1840954. doi:10.3389/fendo.2026.1840954

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →